Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels
- PMID: 2472412
- DOI: 10.1002/jcp.1041390309
Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels
Abstract
The growth of MG63 human osteosarcoma cell line in 5% serum is stimulated by epidermal growth factor (EGF), platelet-derived growth factor (PDGF), or heparin-binding growth factor-1 (HBGF-1). The mitogenic effect of EGF and PDGF is completely blocked by TFG-beta at 1 ng per ml and the effect of HBGF-1 is attenuated by 75-80%. Treatment of MG63 cells with TGF-beta reduces HBGF-1 receptor binding affinity from 1.24 x 10(-11) M to 3.51 x 10(-11) M with no change on the receptor number (1.1 x 10(3) per cell). The receptor-binding affinity of EGF and PDGF is not altered by TGF-beta treatment; however, the number of EGF receptor is increased by 25%. Both EGF and PDGF stimulate MG63 cellular tyrosine kinase activity, and such stimulation is inhibited by TGF-beta pretreatment. No change in the cellular protein tyrosine phosphorylation pattern can be detected in HBGF-1-stimulated cells with and without TGF-beta pretreatment. These data suggest that TGF-beta inhibits EGF and PDGF mitogenicity by blocking EGF- and PDGF-stimulated tyrosine kinase activity and attenuates HBGF-1 mitogenicity by decreasing its receptor affinity.
Similar articles
-
TGF-beta inhibits the platelet-derived growth factor-induced formation of inositol trisphosphate in MG-63 human osteosarcoma cells.J Cell Physiol. 1990 Dec;145(3):488-95. doi: 10.1002/jcp.1041450314. J Cell Physiol. 1990. PMID: 1703169
-
Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide.J Cell Physiol. 1989 Nov;141(2):420-30. doi: 10.1002/jcp.1041410224. J Cell Physiol. 1989. PMID: 2530243
-
Transforming growth factor-beta 1 inhibitory effect of platelet-derived growth factor-induced signal transduction on human bone marrow fibroblasts: possible involvement of protein phosphatases.J Cell Physiol. 1992 Sep;152(3):507-19. doi: 10.1002/jcp.1041520310. J Cell Physiol. 1992. PMID: 1324246
-
Tumor secretion of growth factors.Endocrinol Metab Clin North Am. 1991 Sep;20(3):539-63. Endocrinol Metab Clin North Am. 1991. PMID: 1718747 Review.
-
Hormone-induced modification of EGF receptor proteolysis in the induction of EGF action.J Supramol Struct. 1979;12(4):517-31. doi: 10.1002/jss.400120411. J Supramol Struct. 1979. PMID: 233024 Review.
Cited by
-
Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas.J Clin Pathol. 2006 Jun;59(6):585-90. doi: 10.1136/jcp.2005.028373. Epub 2006 Feb 3. J Clin Pathol. 2006. PMID: 16461571 Free PMC article.
-
Epithelial-mesenchymal transition: a potential therapeutic goal for prevention of wound fibrosis?J Burns Wounds. 2006 Nov 30;5:e9. J Burns Wounds. 2006. PMID: 17224971 Free PMC article. No abstract available.
-
Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population.Med Oncol. 2011 Jun;28(2):622-5. doi: 10.1007/s12032-010-9483-6. Epub 2010 Mar 31. Med Oncol. 2011. PMID: 20354825
-
Biological mediators of wound healing: the importance of the big picture.Int Wound J. 2008 Jun;5(3):414-5. doi: 10.1111/j.1742-481X.2008.00481.x. Int Wound J. 2008. PMID: 18593391 Free PMC article. Review. No abstract available.
-
Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study.BMC Cancer. 2010 Apr 29;10:169. doi: 10.1186/1471-2407-10-169. BMC Cancer. 2010. PMID: 20429896 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
